ApoE and cholesterol in schizophrenia and bipolar disorder: Comparison of grey and white matter and relation with APOE genotype

Journal of Psychiatry and Neuroscience

Volumn 36, Issue 1, 2011, Pages 47-55

  Vila Rodriguez, Fidel ^a   Honer, William G ^a   Innis, Sheila M ^a   Wellington, Cheryl L ^a   Beasley, Clare L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAY MATTER; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; TISSUE LEVEL; WHITE MATTER;

EID: 78650744246     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.090116     Document Type: Article

References (55)

1. Honer WG, Falkai P, Chen C, et al. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999;91:1247-55.
2. Rosoklija G, Toomayan G, Ellis SP, et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000;57:349-56.
3. Beasley CL, Honer WG, Bergmann K, et al. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 2005;7:449-55.
4. Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003;362:798-805.
5. Björkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004;24:806-15.
6. Das HK, McPherson J, Bruns GA, et al. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985;260:6240-7.
7. Paik YK, Chang DJ, Reardon CA, et al. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A 1985;82:3445-9.
8. Pitas RE, Boyles JK, Lee SH, et al. Astrocytes synthesize apo - lipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917:148-61.
9. Pfrieger FW, Barres BA. Synaptic efficacy enhanced by glial cells in vitro. Science 1997;277:1684-7.
10. Nathan BP, Jiang Y, Wong GK, et al. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 2002;928:96-105.
11. Handelmann GE, Boyles JK, Weisgraber KH, et al. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res 1992;33:1677-88.
12. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001;12:105-12.
13. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-31.
14. Ignatius MJ, Shooter EM, Pitas RE, et al. Lipoprotein uptake by neuronal growth cones in vitro. Science 1987;236:959-62.
15. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001;294:1354-7.
16. Brandrup E, Randrup A. A controlled investigation of plasma lipids in manic-depressives. Br J Psychiatry 1967;113:987-92.
17. Mahadik SP, Mukherjee S, Correnti EE, et al. Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophr Res 1994;13:239-47.
18. Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand 2003;108:208-14.
19. Lalovic A, Levy E, Luheshi G, et al. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol 2007;10:159-66.
20. Dean B, Laws SM, Hone E, et al. Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biol Psychiatry 2003;54:616-22.
21. Digney A, Keriakous D, Scarr E, et al. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder. Biol Psychiatry 2005;57:711-5.
22. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008;40:827-34.
23. Bellivier F, Laplanche JL, Schürhoff F, et al. Apolipoprotein E gene polymorphism in early and late onset bipolar patients. Neurosci Lett 1997;233:45-8.
24. Beffert U, Cohn JS, Petit-Turcotte C, et al. Apolipoprotein E and 2-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res 1999;843:87-94.
25. Bertrand P, Poirier J, Oda T, et al. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in alzheimer disease. Brain Res Mol Brain Res 1995;33:174-8.
26. Glöckner F, Meske V, Ohm TG. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuro - pathological changes in Alzheimer's disease. Neuroscience 2002;114:1103-14.
27. Riddell DR, Zhou H, Atchison K, et al. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 2008;28:11445-53.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): The Association; 1994.
29. Innis SM, Dyer RA. Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid. J Lipid Res 2002;43:1529-36.
30. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
31. Fagan AM, Holtzman DM, Munson G, et al. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (e//), and human apoE transgenic mice. J Biol Chem 1999;274:30001-7.
32. Haas C, Cazorla P, Miguel CD, et al. Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease betaamyloid precursor protein. Biochem J 1997;325:169-75.
33. Chapman J, Estupiñan J, Asherov A, et al. A simple efficient method for apolipoprotein E genotype determination. Neurology 1996;46:1484-5.
34. Barakauskas VE, Beasley CL, Barr AM, et al. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 2010;35:1226-38.
35. Söderberg M, Edlund C, Kristensson K, et al. Lipid compositions of different regions of the human brain during aging. J Neurochem 1990;54:415-23.
36. Rickhag M, Deierborg T, Patel S, et al. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab 2008;28:551-62.
37. LaDu MJ, Gilligan SM, Lukens JR, et al. Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 1998;70:2070-81.
38. Huang JT, Wang L, Prabakaran S, et al. Independent proteinprofiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. Mol Psychiatry 2008;13:1118-28.
39. Thomas EA, Dean B, Pavey G, et al. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci U S A 2001;98:4066-71.
40. Morrow JA, Segall ML, Lund-Katz S, et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 2000;39:11657-66.
41. Gong JS, Kobayashi M, Hayashi H, et al. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem 2002;277:29919-26.
42. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world: Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999;63:301-10.
43. Harrington CR, Roth M, Xuereb JH, et al. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizo - phrenia. Neurosci Lett 1995;202:101-4.
44. Lan TH, Hong CJ, Chen JY, et al. Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol Psychiatry 1997;42:225-7.
45. Martorell L, Virgos C, Valero J, et al. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol Psychiatry 2001;6:307-10.
46. Powchik P, Friedman J, Haroutunian V, et al. Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 1997;42:296-8.
47. Town T, Fallin D, Crawford F, et al. Lack of association between the apolipoprotein E epsilon4 allele (APOE epsilon4) and chronic schizophrenia. Am J Med Genet 1997;74:451-2.
48. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific inter actions of apolipoprotein E with microtubule-associated protein tau: Implications for alzheimer disease. Proc Natl Acad Sci U S A 1994;91:11183-6.
49. Runge MS, Patterson C. Principles of molecular cardiology. Totowa (NJ): Humana Press; 2005.
50. Henderson DC. Schizophrenia and comorbid metabolic disorders. J Clin Psychiatry 2005;66(Suppl 6):11-20.
51. Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 2004;70:1-17.
52. Lütjohann D, Stroick M, Bertsch T, et al. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 2004;69:431-8.
53. Thelen KM, Rentsch KM, Gutteck U, et al. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther 2006;316:1146-52.
54. Thelen KM, Laaksonen R, Päivä H, et al. High-dose statin treat - ment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol 2006;46:812-6.
55. Olsson NU, Harding AJ, Harper C, et al. High-performance liquid chromatography method with light-scattering detection for meas - urements of lipid class composition: analysis of brains from alcoholics. J Chromatogr B Biomed Appl 1996;681:213-8.